Hatch: Orrin

Henry Waxman, Democratic representative from California since 1975. In an unusual instance of cooperation across parties, Waxman cosponsored a bill in 1984 with conservative Republican senator Orrin Hatch called the Drug Price Competition and Patent Restoration Act. The bill helped consumers by making it easier and faster for less expensive generic drugs to get approval from the FDA. It helped drug companies by allowing their patents to be extended when the development and approval process took a particularly long time. 

The Law of Biologic Medicine Hearing Before the Subcommittee, on the Judiciary, 108th Cong. 1 (2004) (statement of Sen. Orrin Hatch, Chairman, Subcommittee, on the Judiciary). 

The DSHEA was a bipartisan bill cosponsored by Orrin Hatch of Utah and Tom Harkin of Iowa. First, it broadened the definition of a dietary supplement to include any product designed to supplement the diet that contained one or more of the following a vitamin, mineral, herb, botanical, amino acid, or any metabolic constituent or extract thereof. To be removed from the market, supplements must be proven unsafe by the FDA. This is in contrast to drugs, where the burden of proof (both safety and efficacy) is on the manufacturer. Supplements must contain the labeling Not evaluated... 

---